In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality
- PMID: 35500262
- DOI: 10.7326/J22-0025
In adults hospitalized with COVID-19, adding remdesivir to standard care did not reduce in-hospital mortality
Abstract
Ali K, Azher T, Baqi M, et al. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ. 2022;194:E242-51. 35045989.
Comment on
-
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.CMAJ. 2022 Feb 22;194(7):E242-E251. doi: 10.1503/cmaj.211698. Epub 2022 Jan 19. CMAJ. 2022. PMID: 35045989 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources